From August 5, 2022 to December 21, 2022, the company has repurchased 1,585,320 shares, representing 0.17% for CNY 200.17 million. With this, the company has completed the repurchase of 1,585,320 shares, representing 0.17% for CNY 200.17 million under the buyback announced on August 6, 2022.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Equities
603392
CNE100004090
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
69.22 CNY | +1.38% | +1.05% | -7.87% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.87% | 12.18B | |
-2.47% | 88.14B | |
+1.45% | 40.44B | |
-14.43% | 32.24B | |
+52.79% | 24.39B | |
-14.85% | 15.59B | |
-13.87% | 12.14B | |
-39.40% | 12.3B | |
+6.29% | 8.87B | |
-6.67% | 8.41B |
- Stock Market
- Equities
- 603392 Stock
- News Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Tranche Update on Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s Equity Buyback Plan announced on August 6, 2022.